Higlights of Canadian research and policy news.

This news brought to you by the Murray Alzheimer Research and Education Program and brainXchange. 

Strategy to Address Needs of Aging Population with Increased Long-Term Care Beds in Peterborough Area Announced


Tuesday, February 20, 2018

As part of the Aging with Confidence: Ontario’s Action Plan for Seniors, the Ontario government has announces an investment of 128 new long-term care beds in the Peterborough area. This new home will also be part of the Township of Havelock-Belmont-Methuen’s “health campus” – a development that includes affordable housing for all ages. With this announcement, the government is reaching out to other communities encouraging they apply for new beds as part of the promise to create 5000 long-term care beds in the next four years.

Read More

Strategy to Address Needs of Aging Population with Increased Long-Term Care Beds in Peterborough Area Announced

Tuesday, February 20, 2018

As part of the Aging with Confidence: Ontario’s Action Plan for Seniors, the Ontario government has announces an investment of 128 new long-term care beds in the Peterborough area. This new home will also be part of the Township of Havelock-Belmont-Methuen’s “health campus” – a development that includes affordable housing for all ages. With this announcement, the government is reaching out to other communities encouraging they apply for new beds as part of the promise to create 5000 long-term care beds in the next four years.

Read More

Heart Defects Increase Risk of Dementia Later in Life

Tuesday, February 20, 2018

Research out of the Department of Clinical Epidemiology at Aarhus University Hospital was the first to identify a link between being born with a heart defect and the development of dementia. The study found that those who survived a heart defect at birth were at a higher risk of developing any form of dementia. Utilizing Danish medical databases and records, over 10 thousand adults who were born between 1890 and 1982 with a heart defect were matched with 10 people born in the same year and compared.

Read More

New Test to Accurately Diagnose Lewy Body Dementia, Alzheimer's Disease and Parkinson's

Tuesday, February 20, 2018

Originally designed to test for prion disease, a testing system for cerebral spinal fluid was moderately altered to identify Lewy body dementia, Alzheimer’s disease and Parkinson’s. The similarity between prion diseases and dementias and Parkinson’s disease is in the accumulation of abnormal protein clumping.  Alpha-synuclein protein, otherwise known as Lewy bodies, accumulate and progressively deteriorate the brain, causing functional decline and eventual death.

Read More

Mind Over Matter: Alzheimer's Risk Reduced by Half With Positive Thinking

Monday, February 12, 2018

A study conducted with over 4000 older adults (aged 60+) by Yale University found that positive beliefs on aging had a significant impact on the development of dementia. They found that participants who had positive beliefs on aging reduced their risk of dementia by 44 percent, and that those who had a genetic predisposition for dementia the risk almost halved. Dr. Levy and her colleagues recruited 4765 “dementia free” adults, with an average age of 72.

Read More

Shared Excitement on Exosomes Causes Texas A&M and Celltex to Team Up on Alzheimer's Research

Monday, February 12, 2018

Exosomes are vesicles created by the cell to transport components through the body. The particular type of exosome that is creating excitement in Alzheimer’s research is exosomes that deliver anti-inflammatory agents to the brain. Celltex Therapeutics Corp. and Texas A&M University Health Science Center College of Medicine Institute for Regenerative Medicine have teamed up to pursue research on how to utilize exosomes to reduce inflammation in the brain.

Read More

A Form of Vitamin B3 Promotes Brain Health and Reduces Cognitive Decline in Mice Models

Monday, February 12, 2018

Researchers from the National Institute on Aging presented in a study on mice the potential benefits of nicotinamide riboside (NR), a form of the vitamin B3 supplement, for protecting against Alzheimer’s disease and cognitive decline. Utilizing genetically modified mice to exhibit traditional Alzheimer’s pathology (such as the presence of tau and amyloid beta proteins), the researchers tested the effect the NR supplement had on their cognitive abilities and brain pathology.

Read More

Canadian Research from Alberta Takes a New Approach to Alzheimer's Research

Monday, February 12, 2018

Professors, Matthew Macauley and John Klassen, from the University of Alberta are investigating how glycomics, the study of carbohydrates (sugars) may be linked to Alzheimer’s disease. Determining how the glycans (sugars) interact with a protein known as CD33, which has strong implications in Alzheimer’s disease, may create potential therapies. The researchers explain that receptors for sugars in microglia (white blood cells found in the brain) can serve as an indicator of who will develop Alzheimer’s disease.

Read More

New Alzheimer’s Detection Tool Being Tested at Laurier University

Monday, February 5, 2018

Professors at Wilfrid Laurier University (WLU) (Lazaridis School of Business and Economics) have partnered with BrainFX, Thought Wire, and Saint Elizabeth Health Care to produce a new early detection tool for Alzheimer’s disease.

Read More

MIND Diet Promotes Brain Health and Lowers Risk of Dementia in Stroke Survivors

Monday, February 5, 2018

The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND) diet was developed by researchers from the Rush University Medical Centre to promote brain health, and reduce risk of hypertension, heart attack, and stroke. This diet has also been seen to slow cognitive decline in those who have experienced a stroke - who are far more likely to develop dementia over time.

Read More
Displaying results 1-9 (of 10)
  < 1 - 2  > 
The brainXchange does not endorse the content of these stories, you may use this as a starting point for your own investigations.